Efficacy and safety of EGFR‑TKIs plus Shenqi Fuzheng injection for non-small cell lung cancer patients with EGFR-sensitive mutations

PURPOSE: The aim of this retrospective study is to evaluate the impact on efficacy and safety between epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) alone and in combination with Shenqi Fuzheng injection (SFI) in patients with advanced NSCLC harboring epidermal growth factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jia-li, Chen, Chuan-sheng, Jia, Zhi-rong, Miao, Li-yun, Xie, Jun, Pan, Zhen-zhen, Duan, Ya-lei, Liu, Shuo, Hou, Meng-jun, Ding, Xuan-sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314878/
https://www.ncbi.nlm.nih.gov/pubmed/36008690
http://dx.doi.org/10.1007/s00432-022-04297-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314878/
https://www.ncbi.nlm.nih.gov/pubmed/36008690
http://dx.doi.org/10.1007/s00432-022-04297-3

Ejemplares similares